By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

YEAR FOUNDED:

1858

LEADERSHIP:

Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Bristol-Myers Squibb job opportunities.

PRODUCTS:

Please click here to see all products.

For more information, visit
www.bms.com and follow us on www.twitter.com/BMSNEWS.

FOLLOW BRISTOL-MYERS SQUIBB:





Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Bristol-Myers Squibb (BMY) And Pfizer (PFE) To Highlight Commitment To Reducing The Risk Of Stroke Caused By Non-Valvular Atrial Fibrillation (NVAF) And Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) At ESC Congress 2017 8/18/2017 7:15:49 AM
Disappointment Over Bristol-Myers Squibb (BMY)'s Kidney Combo Boosts Bay Area's Exelixis (EXEL) 8/17/2017 7:06:38 AM
Bristol-Myers Squibb (BMY)'s Stock Topples as Kidney Cancer Drug Flunks Phase III Study 8/16/2017 5:08:33 AM
Regen BioPharma Addresses Potential Impact of Recent Bristol-Myers Squibb (BMY)'s $2.3 Billion Acquisition Of IFM Therapeutics 8/10/2017 1:48:35 PM
Pharma Giant Bristol-Myers Squibb (BMY) Plans Layoffs, Effective Oct. 6 8/10/2017 7:58:01 AM
Regen BioPharma Addresses Potential Impact Of Recent Bristol-Myers Squibb (BMY) $2.3 Billion Acquisition Of IFM Therapeutics 8/9/2017 11:57:00 AM
This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb (BMY) 8/4/2017 7:47:25 AM
Seattle Genetics (SGEN) Nabs Bristol-Myers Squibb (BMY)’s Bothell MFG Facility, Plans to Offer Jobs to Current Employees 8/2/2017 6:13:53 AM
Bristol-Myers Squibb (BMY) Receives FDA Approval For Opdivo (Nivolumab) In MSI-H Or Dmmr Metastatic Colorectal Cancer That Has Progressed Following Treatment With A Fluoropyrimidine, Oxaliplatin, And Irinotecan 8/1/2017 6:37:16 AM
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III 7/31/2017 7:00:47 AM
12345678910...
//-->